A pivotal ITC decision marks a major shift in the legal battle surrounding Oura’s smart-ring technology.
In a category built on sleep scores and wellness nudges, the most consequential stat this year came from a courtroom.
The U.S. International Trade Commission finalized a ruling that Ultrahuman and RingConn infringed Oura’s smart ring patent, triggering exclusion and cease-and-desist orders that block their rings from the U.S. market after the presidential review period ended in October 2025.
Days later, Oura moved to widen the battlefield with a new ITC complaint naming Samsung’s Galaxy Ring, Reebok’s ring, Zepp Health’s Amazfit Helio Ring, and Nexxbase’s Luna Ring, signaling that access to the U.S. channel may now hinge on licensing Oura’s intellectual property or fighting it head-on.
What Happened
- The ITC found a violation of Section 337 tied to Oura’s asserted patent, and the final ruling now bans import and sale of Ultrahuman and RingConn smart rings in the U.S., with cease-and-desist orders in effect after review completed in October 2025.
- RingConn has separately reached a settlement with Oura, according to multiple reports, while Ultrahuman is appealing and has pursued its own litigation in India, where a court recently reinstated Ultrahuman’s case against Oura, keeping that front active outside the U.S..
- Oura has filed a fresh ITC action that targets Samsung, Reebok, Zepp Health, and Nexxbase, asserting infringement tied to the smart ring form factor and internal component architecture, and industry coverage indicates Oura seeks royalties or restrictions similar to its earlier actions.
The Core Tech, Explained
Think of a smart ring as a tiny, sealed lab on your finger. It wraps a curved battery, sensor array, and radios inside a minimal band, then runs firmware that translates raw signals into sleep staging, readiness, and recovery scores you can understand.
Oura’s asserted patent scope, based on public summaries and filings, centers on the ring form factor and component integration that make the device both comfortable and continuously measurable, which is why lookalike dimensions and internal layouts have become legal flashpoints rather than mere industrial design debates.
When courts test these claims, they analyze whether competing products meet each element of asserted claims, and the ITC’s record indicates it found infringement on every element of the asserted claims in the Ultrahuman and RingConn case.
Why It Matters Now
- Market access: U.S. distribution is the prize. An exclusion order changes retail roadmaps, carrier partnerships, and software support strategies overnight, which is why settlement, licensing, or redesign becomes an urgent decision point for ring makers.
- Timing: 2025 is the year big brands entered the ring category. Oura’s new complaint now touches Samsung’s Galaxy Ring and other new entrants, raising the odds that licensing will define who scales in 2026 rather than pure hardware merit alone.
- Precedent: The Section 337 outcome and final orders set a template. If Oura repeats its success, competitors may face a choice between paying royalties, redesigning, or risking U.S. channel disruption.
Investigative Insight
- Strategy by litigation: Oura appears to be using a dual lever. First, a strong ITC outcome provides leverage. Second, simultaneous complaints against multiple rivals assert a licensing-first path for market participation, which could compress margins for late entrants but stabilize Oura’s economics as a platform licensor.
- Global chessboard: The Delhi High Court’s reinstatement of Ultrahuman’s suit against Oura shows that outside the U.S., the legal narrative is not one-way. Global players may fragment their strategies by region, licensing where necessary in the U.S. and contesting claims elsewhere.
- Consumer impact: Near term, U.S. buyers may see fewer choices or delayed launches while companies negotiate or redesign. Midterm, expect clearer differentiation through software features, AI-driven insights, and women’s health tooling, once legal boundaries on core hardware configurations settle.
Who Is Affected
- Consumers: If you planned to buy Ultrahuman in the U.S., availability has been cut off, and support commitments may change. If you are eyeing a Galaxy Ring or other new brands, watch for licensing updates or design tweaks before broad U.S. retail.
- Competitors: Brands now face IP diligence as a go-to-market step. Partnerships and licensing deals can become as critical as firmware updates, since any misstep risks an exclusion order that nullifies marketing and distribution.
- Retailers and platforms: Channel partners will likely hedge assortments toward licensed, compliant rings to reduce returns and regulatory headaches, while software ecosystems prepare for SKU volatility tied to legal outcomes.
What Could Happen Next
- Licensing wave: Settlements could expand, with brands announcing agreements to keep U.S. timelines intact. Expect royalties built into the bill-of-materials and possible co-promotion of compliant designs.
- Redesign paths: Hardware reworks that avoid specific claim elements may surface, though this risks fit, battery life, or sensor performance that made ring form factors compelling in the first place.
- A Samsung inflection: If Samsung licenses, it normalizes the toll model. If it fights, the case could test patent scope against a top-tier engineering and legal team, setting a durable precedent for the category.
The So What
Smart rings promised invisible computing that feels human. The next phase of that promise will be defined not only by signal quality and AI, but by who owns the blueprint for a comfortable, continuous, medically meaningful ring form factor.
Oura’s patent battle is not just a legal story. It is the new operating system for market access in wearables, and the winners will be the companies that align product roadmaps with clear IP contours while still shipping experiences that people love to wear every day.
About the Author
